• Follow
  • Follow
  • Menu Item

Log in

Start free trial
  • Reports
    • Diagnostic Testing & Emerging Technologies
    • Lab Compliance Advisor
    • Laboratory Industry Report
    • National Lab Reporter
  • Articles
    • Diagnostic Testing and Emerging Technologies
      • DTC-dtet
      • Earnings-dtet
      • Emerging Tests-dtet
      • FDA-dtet
      • G2 Insider-dtet
    • Lab Compliance Advisor
      • Accreditation-lca
      • Brief Your CEO-lca
      • CLIA-lca
      • CMS-lca
      • Coding-lca
      • Compliance Corner-lca
      • Compliance Guidance-lca
      • Compliance Officers-lca
      • Compliance Perspectives-lca
      • Compliance Plans-lca
      • Compliance-lca
      • DOJ-lca
      • Employment-lca
      • Enforcement-lca
      • False Claims-lca
      • FDA-lca
    • Laboratory Industry Report
      • Capital-lir
      • CMS-lir
      • Deals-lir
      • Dx Pipeline-lir
      • Earnings-lir
      • Enforcement-lir
      • FDA-lir
      • Fee Schedules-lir
      • Funding-lir
    • National Lab Reporter
      • Guidelines at a Glance-nir
      • Health care reform-nir
      • HIPAA-nir
      • Labs in Court-nir
      • Legislation-nir
      • News-nir
      • OIG-nir
      • Reimbursement-nir
      • Safety-nir
  • News
  • Industry Perspectives
  • Webinars
  • Store

Diagnostic Testing and Emerging Technologies

LAB COMPLIANCE ADVISOR

LABORATORY INDUSTRY REPORT

NATIONAL LAB REPORTER

Senators to HHS: Keep Covering At-Home COVID-19 Tests After PHE Ends

Senators to HHS: Keep Covering At-Home COVID-19 Tests After PHE Ends

by Glenn S. Demby | Apr 17, 2023 | News

Group of 18 senators says ending Medicare coverage for at-home COVID-19 tests would undo efforts to contain spread of the coronavirus.

FDA Keeps COVID-19 EUA Pipeline Open While Working toward Transition

FDA Keeps COVID-19 EUA Pipeline Open While Working toward Transition

by Glenn S. Demby | Mar 30, 2023 | FDA-lir, Laboratory Industry Report

HHS secretary takes action to ensure that EUAs remain in effect until the “significant potential” for a COVID-19 PHE no longer exists.

This content is for Paid Members only.
Login Register
FDA to Keep COVID-19 EUA Pipeline Open for Now

FDA to Keep COVID-19 EUA Pipeline Open for Now

by Glenn S. Demby | Mar 29, 2023 | News

U.S. Department of Health and Human Services secretary takes action to ensure continued access to COVID-19 EUA products.

The End of COVID-19 PHE: Practical Implications for Clinical Labs

The End of COVID-19 PHE: Practical Implications for Clinical Labs

by G2 Intelligence Staff | Mar 14, 2023 | Webinars, webinars free

In this webinar, our expert speakers will share what the end of the COVID-19 PHE will mean for clinical labs and how they can best prepare.

Special Report: What Next for COVID-19 Tests?

Special Report: What Next for COVID-19 Tests?

by Glenn S. Demby | Feb 16, 2023 | Diagnostic Testing and Emerging Technologies, Top of the News-dtet

An overview of what will happen to the COVID-19 tests issued via EUA once the public health emergency ends on May 11.

This content is for Paid Members only.
Login Register
« Older Entries
Next Entries »

Log In


Join Now | Lost Password?

  • Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
Copyright © 2023 G2Intelligence.com